PL
Polaryx Therapeutics, Inc. Common Stock (PLYX)
NASDAQ·Healthcare·Biotechnology
$5.62
+10.75%
Mkt Cap $240.03M
No analyst coverage available
We don't have analyst ratings or price target data for Polaryx Therapeutics, Inc. Common Stock yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.